We are excited to announce the fifth annual SoCal Genome Stability Symposium. The Symposium is coordinated in partnership by Scripps Research, City of Hope and the University of Southern California. The SoCal Genome Stability Symposium offers postdoctoral associates and graduate students the opportunity to present their current research and to connect with their peers from...
For 20 years, Bio-IT World has connected the people, ideas, and opportunities of the life science industry to accelerate R&D and drive the future of medicine. The 20th annual event will highlight how far we’ve come, celebrate new victories, and shed light on what’s next for biomedical research, drug discovery and development, and healthcare. Access...
2021 ISPE Biotechnology Conference & Workshop Now a Virtual Experience: 2021 ISPE Biotechnology Conference As the COVID-19 pandemic continues to have an unforeseeable global impact, ISPE must constantly evaluate the delivery of our professional development opportunities to keep knowledge thriving while ensuring the safety of our community. In that regard, we will transform the 2021 ISPE...
Biocom California’s HR Conference for Life Science is dedicated to HR professionals working within the life science industry across the state of California. In 2021, this strategic-level conference will be delivered in a hybrid format. The statewide conference will take place over the span of three weeks, connecting the HR communities across California, and providing...
Women executives in pharma and healthcare who have climbed every obstacle to get to the top share their success stories to educate and inspire the next generation of leaders. This program challenges and guides attendees to empower women in leadership roles and continue to close the gender parity industry gap.
The 20th Precision Medicine World Conference (PMWC) will take place at the Wyndham Grand Pittsburgh Downtown on September 23 and 24, 2021 in partnership with the University of Pittsburgh and UPMC. UPMC is the largest academic healthcare system in the US. This city of steel has re-emerged as the city of Eds and Meds with...
NOTE: 8:30-12:30 PST Drug interaction is an important consideration throughout drug development. Since each drug candidate has its unique drug interaction profile in the context of the intended indication, there are no universally accepted strategies for evaluating drug interaction potentials; however, but there are generally adopted drug interaction strategies and practices developed by the industry...
Vaccine Town Hall: Boosters & Breakthroughs is a free, virtual program designed to provide an update on the status of vaccine boosters, breakthrough cases, and the future of mandates in Pennsylvania. Attendees will hear from industry experts, and are encouraged to bring questions to this informative and timely town hall.
Each year, Global Genes convenes one of the world’s largest gatherings of rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners and allies. Join us for a variety of interactive and educational events, meet-ups, workshops and networking opportunities. Here you’ll have the opportunity to connect and engage with others in the rare disease community, while...
COVID-19 put mobile digital technology on the fast-track, ushering in a new era of patient connectivity. Capitalizing on this moment will require working through many of the existing hurdles of fit for purpose, patient compliance, adoption, scale and just getting it done. The 8th annual Mobile in Clinical Trials will feature the latest examples on...
Formulate, scale and standardize out-of-this-world launch strategies to bring your C>s to market fast and effectively. While some developers are implementing lessons learned – and launching – their 2nd C>s to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts,...
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patient feedback....
